Share on

Global Atrial Fibrillation Surgery Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Surgical Procedure, Product & Region - Industry Forecasts (2023 to 2028)

Published: March, 2023
ID: 3912
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Atrial Fibrillation Surgery Market Size (2023 to 2028)

The global atrial fibrillation surgery market size was valued at USD 1.95 billion in 2022. This market is forecasted to grow at a CAGR of 14.14% and reach USD 3.78 billion by 2028.

Atrial fibrillation, also called AFib or AF, doubles the risk of death. In addition, it increases the risk of stroke five to seven times. The increasing awareness about different treatment processes of the atrial fibrillation condition is boosting the market growth. It is estimated that 1 of the nine people below the age of 60 is affected by atrial fibrillation, directly resulting in the demand for the treatment. Patients with atrial fibrillation live with an increased morbidity and mortality risk, thus giving rise to the need for atrial fibrillation.


Y-O-Y growth in the incidence of atrial fibrillation is majorly propelling the global atrial fibrillation surgery market growth.

As per the Centers for Disease Prevention and Control (CDC), the prevalence of AFib is predicted to range between 2.7 million to 6.1 million. This value is forecasted to hit 12.1 million by 2030, estimated to provide significant growth to the global article fibrillation market. In addition, the rising cases of obesity, hypertension, and heart conditions are helping the growth of the market. Furthermore, growing cardiac problems coupled with the rising demand for atrial fibrillation surgery is helping raise the demand for the market.

The growing prevalence of minimally invasive procedures boosts the market's growth rate. Increasing expenditure on healthcare is also propelling the demand of the market. The cost of the procedure of atrial fibrillation surgery is low; thus, there is a considerable increase in the need for the procedure. In addition, there is a tremendous technological advancement in atrial fibrillation surgery, improving the cure rate of the patient. 

Key players and technological developments to promote market revenue.

Furthermore, the rising research and development in the atrial fibrillation surgery market and the mergers and acquisitions among key market players to help the market growth is expected to promote revenue. Several new trials are conducted, and product launches are initiated to help the market grow. For example, the latest trial, called the LeAAPS trial (left atrial appendage occlusion), in patients with cardiac surgery who might be at risk of a heart stroke. The safety and efficiency of the surgery are now under discussion with the researchers. Additionally, technologies like the pulsed field ablation technology released this year that allows safer and faster atrial ablation procedures are helping markets uprise. 


However, rising complications in real-time applications are hindering the demand of the market. The high cost of treatment procedures is additionally degrading the revenue of the atrial fibrillation market. The increasing preference towards pharmacological drugs to replace surgical needs and depend on medicines to treat atrial fibrillation is expected to drive the growth of this market. 

Impact of COVID-19 on the global atrial fibrillation surgery market:

The COVID-19 pandemic has significantly affected the global economy at various levels, including the healthcare sector. Due to the shutdown of production facilities, extreme shortages of raw materials, and the absence of potential human resources, the booming healthcare research, and development industry will likely see a sharp drop in revenue during the lockdown period. A quivering or irregular heartbeat, also known as arrhythmia (Atrial fibrillation), can cause blood clots, strokes, cardiac failure, and other heart-related issues. For COVID-19 patients, AFib exacerbates a highly uncomfortable condition. Before the root cause of COVID-19 is tackled, it is generally far too late - until people are on a ventilator, in the increased, struggling for their life - to fix an unresolved arrhythmia, which is often untreatable. Due to this, the demand for atrial fibrillation stroke therapy is widely competitive and has a positive growth in the market. Major players are concentrating their resources on working with the heart research center to create a better version of medicine to treat atrial fibrillation stroke and Covid-19 Patients.




Market Size Available

2022 to 2028

Base Year


Forecast Period

2023 to 2028

Segments Covered

By Surgical Procedure, Product, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global atrial fibrillation surgery market has been segmented and sub-segmented based on the surgical procedure, product, and region.

Atrial Fibrillation Surgery Market - By Surgical Procedure:

  • Catheter Ablation procedure
  • Surgical Ablation
  • Maze procedure

Based on the surgical procedure, the Catheter Ablation Procedure segment held the largest share in 2019 and is estimated to grow with the highest CAGR during the forecast period. Factors like increasing demand for non-pharmaceutical treatments, growing patient awareness, and improved healthcare groundwork significantly push the global atrial fibrillation surgery market.

Atrial Fibrillation Surgery Market - By Product:

  • Catheter Ablation
  • Surgical Ablation

Based on the product, Catheter ablation surgical devices are expected to be the largest segment. They are also likely to be the fastest-growing segment due to their high acceptance of surgical procedures. In addition, catheter ablation is a minimally invasive procedure, and it helps reduce irregular heartbeats (arrhythmia) in patients, further promoting the segment's expansion. It is the most preferred and the most commonly used method to help relieve atrial fibrillation when open heart surgery is not required. It helps the patients heal quickly and return to their healthy physical state.

However, the surgical ablation segment is also expected to be a close second to the growing market revenue. Even though the surgical ablation procedure is more invasive and majorly used in an open heart surgery setting, it is beneficial for surgeons to maintain stability during complex surgeries. Sometimes, surgical catheter only uses small incisions on the rib cage and is not overly invasive. In addition, the camera sent in during surgical catheter helps get a better understanding of the heart's situation, promoting growth for the market. 

Atrial Fibrillation Surgery Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, the North American regional market had dominated the global atrial fibrillation surgery market in the recent past and is predicted to continue the same during the forecast period due to the availability of highly advanced healthcare infrastructure and the adoption of highly advanced technologies. In addition, the presence of high volumes and complicated healthcare substructure, massive patient awareness, and increasing healthcare expenditure levels are expanding the market size in this region. Therefore, the U.S. atrial fibrillation surgery market is projected to have a potential growth rate during the forecast period.

During the forecast period, the European market occupied the second largest market share in the atrial fibrillation surgery market. The market growth is due to growing elder people population is one primary factor driving the market growth. The U.K is the leading nation in the market due to growing incidences of atrial fibrillation and rising healthcare awareness, and Germany will show lucrative growth over the period due to the increasing economy and adoption of the latest technologies.

The Asia Pacific is expected to be the fastest-growing segment due to the large senior population with a high risk of heart disease. Regulatory policies in Asia-Pacific countries are more flexible and business-friendly. It is due to the ubiquity of less strict regulations and data needs. China's atrial fibrillation surgery market will grow at a healthy rate due to a huge patient pool and healthcare expenditure integrated with increasing awareness in people. Growth is due to a vast number of elder people population who are prone to high risk of heart diseases in countries like China and India.

Latin America region is observed to have a steady growth in the atrial fibrillation surgery market. Brazil is the leading nation in this region. The increase in Brazil is due to the development of the healthcare sector. In addition, the prevalence of minimally non-invasive surgeries is escalating the growth rate of the market.

The Middle East & Africa region shows a significant growth rate due to the increasing awareness of people. South Africa will have a steady growth rate in the forthcoming years due to increasing knowledge of advanced treatment processes. The growth rate in Saudi Arabia is propelling due to increasing lifestyle changes and the growing obese population.


Some of the notable players operating the global atrial fibrillation surgery market profiled in the report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc., Cardiofocus, Inc., contact, Inc., and Biotronik SE & Co.


  • In October 2022, the first radiofrequency balloon ablation catheter by the name HELIOSTAR was launched in Europe by a med tech company which is a part of Johnson and Johnson called biosense Webster. The machine is designed to help make cardiac ablations more efficient and to help make the job easier for physicians.  
  • In October 2022, An attempt is being made to create an ablation technology that does not cause any side effects like causing damage to areas other than the targetted in the heart by a technological company called Stem Tronics. In addition, a significant investigation device exemption trial is being performed to produce pulsed electric fields and target specific heart regions. 
  • In October 2022, heartbeam, a heart devices manufacturing company, is now initiating the development of a heart device that can be connected to the patient's smartwatch for continuous monitoring of the heart in various patterns, including atrial fibrillation needs. The California-based company is creating this wearable device to make it easier for remote health monitoring systems. 
  • In May 2020, the US FDA approved the next-generation CardioFocus Inc. HeartLight X3 Endoscopic ablation system to treat drug-refractory recurrent symptomatic paroxysmal atrial fibrillation. 

Please wait. . . . Your request is being processed


who are the key players of the global atrial fibrillation surgery market ?

Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., and Articure, Inc are some of the notable key players in the global atrial fibrillation surgery market.

what is the compound annual growth rate (CAGR%) of the global atrial fibrillation surgery market during the forecast period?

The global atrial fibrillation surgery market is expected to grow at a CAGR of 14.4% during the forecast period.

which region accounted for the largest share in the  global atrial fibrillation surgery market  ?

The  global atrial fibrillation surgery market  in North America is expected to grow significantly and hold the largest share of the revenue during the forecast period.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample